665 related articles for article (PubMed ID: 24280342)
1. Activation of paraoxonase 1 is associated with HDL remodeling ex vivo.
Gugliucci A
Clin Chim Acta; 2014 Feb; 429():38-45. PubMed ID: 24280342
[TBL] [Abstract][Full Text] [Related]
2. Activation of paraoxonase 1 after hemodialysis is associated with HDL remodeling and its increase in the HDL2 fraction and VLDL.
Gugliucci A; Kinugasa E; Ogata H; Caccavello R; Kimura S
Clin Chim Acta; 2014 Mar; 430():9-14. PubMed ID: 24384301
[TBL] [Abstract][Full Text] [Related]
3. Paraoxonase 1 and HDL maturation.
Gugliucci A; Menini T
Clin Chim Acta; 2015 Jan; 439():5-13. PubMed ID: 25261854
[TBL] [Abstract][Full Text] [Related]
4. Evidence for the presence of active paraoxonase 1 in small-dense low-density lipoprotein.
Gugliucci A; Caccavello R; Kotani K; Kimura S
Redox Rep; 2014 Jul; 19(4):154-60. PubMed ID: 24524596
[TBL] [Abstract][Full Text] [Related]
5. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
[TBL] [Abstract][Full Text] [Related]
6. Visceral leishmaniasis is associated with marked changes in serum lipid profile.
Liberopoulos EN; Apostolou F; Gazi IF; Kostara C; Bairaktari ET; Tselepis AD; Elisaf M
Eur J Clin Invest; 2014 Aug; 44(8):719-27. PubMed ID: 24920396
[TBL] [Abstract][Full Text] [Related]
7. ApoE induces serum paraoxonase PON1 activity and stability similar to ApoA-I.
Gaidukov L; Viji RI; Yacobson S; Rosenblat M; Aviram M; Tawfik DS
Biochemistry; 2010 Jan; 49(3):532-8. PubMed ID: 20025294
[TBL] [Abstract][Full Text] [Related]
8. VLDL triglycerides inhibit HDL-associated paraoxonase 1 (PON1) activity: in vitro and in vivo studies.
Rosenblat M; Ward S; Volkova N; Hayek T; Aviram M
Biofactors; 2012; 38(4):292-9. PubMed ID: 22674772
[TBL] [Abstract][Full Text] [Related]
9. Distribution of Paraoxonase-1 (PON-1) and Lipoprotein Phospholipase A2 (Lp-PLA2) across Lipoprotein Subclasses in Subjects with Type 2 Diabetes.
Passaro A; Vigna GB; Romani A; Sanz JM; Cavicchio C; Bonaccorsi G; Valacchi G; Cervellati C
Oxid Med Cell Longev; 2018; 2018():1752940. PubMed ID: 30524650
[TBL] [Abstract][Full Text] [Related]
10. High affinity, stability, and lactonase activity of serum paraoxonase PON1 anchored on HDL with ApoA-I.
Gaidukov L; Tawfik DS
Biochemistry; 2005 Sep; 44(35):11843-54. PubMed ID: 16128586
[TBL] [Abstract][Full Text] [Related]
11. Association between paraoxonase-1 activity and lipid peroxidation indicator levels in people living in the Antalya region with angiographically documented coronary artery disease.
Göçmen AY; Gümüşlü S; Semiz E
Clin Cardiol; 2004 Jul; 27(7):426-30. PubMed ID: 15298047
[TBL] [Abstract][Full Text] [Related]
12. Low protective PON1 lactonase activity in an Arab population with high rates of coronary heart disease and diabetes.
Gugliucci A; Caccavello R; Nassar H; Abu Ahmad W; Sinnreich R; Kark JD
Clin Chim Acta; 2015 May; 445():41-7. PubMed ID: 25801214
[TBL] [Abstract][Full Text] [Related]
13. Activity of paraoxonase 1 (PON1) on HDL
Miljkovic M; Stefanovic A; Vekic J; Zeljkovic A; Gojkovic T; Simic-Ogrizovic S; Bogavac-Stanojevic N; Cerne D; Ilic J; Stefanovic I; Jelic-Ivanovic Z; Spasojevic-Kalimanovska V; Kotur-Stevuljevic J
Clin Biochem; 2018 Sep; 60():52-58. PubMed ID: 30130521
[TBL] [Abstract][Full Text] [Related]
14. Vitamin C attenuates hypochlorite-mediated loss of paraoxonase-1 activity from human plasma.
Kunes JP; Cordero-Koning KS; Lee LH; Lynch SM
Nutr Res; 2009 Feb; 29(2):114-22. PubMed ID: 19285602
[TBL] [Abstract][Full Text] [Related]
15. Exclusive association of paraoxonase 1 with high-density lipoprotein particles in apolipoprotein A-I deficiency.
Noto H; Hashimoto Y; Satoh H; Hara M; Iso-o N; Togo M; Kimura S; Tsukamoto K
Biochem Biophys Res Commun; 2001 Nov; 289(2):395-401. PubMed ID: 11716486
[TBL] [Abstract][Full Text] [Related]
16. Association of oxidative stress and PON1 with LDL and HDL particle size in middle-aged subjects.
Vekic J; Kotur-Stevuljevic J; Jelic-Ivanovic Z; Spasic S; Spasojevic-Kalimanovska V; Topic A; Zeljkovic A; Stefanovic A; Zunic G
Eur J Clin Invest; 2007 Sep; 37(9):715-23. PubMed ID: 17696961
[TBL] [Abstract][Full Text] [Related]
17. Human serum Paraoxonase/Arylesterase's retained hydrophobic N-terminal leader sequence associates with HDLs by binding phospholipids : apolipoprotein A-I stabilizes activity.
Sorenson RC; Bisgaier CL; Aviram M; Hsu C; Billecke S; La Du BN
Arterioscler Thromb Vasc Biol; 1999 Sep; 19(9):2214-25. PubMed ID: 10479665
[TBL] [Abstract][Full Text] [Related]
18. The functional and compositional properties of lipoproteins are altered in patients with metabolic syndrome with increased cholesteryl ester transfer protein activity.
Park KH; Shin DG; Kim JR; Hong JH; Cho KH
Int J Mol Med; 2010 Jan; 25(1):129-36. PubMed ID: 19956911
[TBL] [Abstract][Full Text] [Related]
19. Small Dense Low Density Lipoprotein Cholesterol, Paraoxonase 1 and Lipid Profile in Postmenopausal Women: Quality or Quantity?
Mogarekar MR; Kulkarni SK
Arch Med Res; 2015 Oct; 46(7):534-8. PubMed ID: 26348135
[TBL] [Abstract][Full Text] [Related]
20. The effect of HDL-bound and free PON1 on copper-induced LDL oxidation.
Bayrak A; Bayrak T; Bodur E; Kılınç K; Demirpençe E
Chem Biol Interact; 2016 Sep; 257():141-6. PubMed ID: 27510818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
